Profile
Klara A.
Dickinson-Eason worked as an Associate Director of Regulatory Affairs at Scios, Inc. She then served as the VP of Regulatory Affairs & Compliance Officer at CoTherix, Inc. from 2004 to 2007.
In 2015, she became the Chief Regulatory Officer & Senior Vice President at Anthera Pharmaceuticals, Inc. From 2007 to 2014, she held the position of Chief Regulatory Officer & SVP-Corporate Quality at Hyperion Therapeutics, Inc. Klara also worked as the Head of Quality Control & Regulatory Affairs at Dey Laboratories, Inc. from 1993 to 1997.
Currently, she is the Chief Regulatory & Quality Assurance Officer at CymaBay Therapeutics, Inc. starting from 2017.
Ms. Dickinson-Eason obtained her undergraduate degree from Great Falls College MSU.
Former positions of Klara Dickinson-Eason
| Companies | Position | End |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Compliance Officer | - |
| ANTHERA PHARMACEUTICALS, INC. | General Counsel | 2017-06-19 |
| HYPERION THERAPEUTICS INC | Compliance Officer | 2014-02-25 |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Compliance Officer | 2007-10-03 |
| Dey Laboratories, Inc. | General Counsel | - |
Training of Klara Dickinson-Eason
| Great Falls College MSU | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
| Dey Laboratories, Inc. |
- Stock Market
- Insiders
- Klara Dickinson-Eason
